Lung Cancer Screening
Lung cancer is the leading cause of cancer death for men and women in the United States. Today, new research shows that low-dose CT (LDCT) screening can detect lung cancer in its earliest and most treatable stages.
The Lung Cancer screening program at Altru Health System provides an assessment of lung cancer risk and low-dose lung CT for those who are at high risk for developing lung cancer. This program provides individualized, evidenced based care based on the results from the National Lung Cancer Screening Trial (NLST) and years of clinical research. Benefits and potential risks of screening are discussed during your consultation. In addition, a smoking cessation program is offered for current smokers. This program offers management recommendations of any findings and continuity of care, as well as ongoing monitoring.
Who is eligible for the screening?
- Individuals between the ages of 55-74 who are current or former smokers
- Individuals who have smoked 30 or more pack years (the number of years smoked multiplied by the number of packs per day)
- Former smokers who quit within the last 15 years
Initial consultation and follow up:
On the day of your first appointment, you will meet with a nurse practitioner who will review your history and risks of lung cancer. If you are eligible, you will be scheduled for a low-dose CT scan. A radiologist will review the CT scan for abnormalities. The nurse practitioner will call you to explain the results and discuss any findings and appropriate follow up (if any).
Most insurance companies now pay for screening CT scans if patients meet criteria listed above. If your company does not cover the cost, there may be scholarships available to cover part of all of the cost.
NCCN Guidelines for Patients
Screening for Lung Cancer
Screening and Testing to Detect Lung Cancer
For additional information call Altru Cancer Center at 701.780.5400.